Robert Fried Insider Profile
4 Followers
Robert Fried, CEO, Director at Niagen Bioscience, holds 1.67M shares in Niagen Bioscience (Ticker: NAGE), holds 368.67K shares in Fluent (Ticker: FLNT).
Profitable Transactions
8 out of 12 Profitable Transactions
Average Return
+18.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Fried holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Fried
Robert Fried's Trading History
Niagen Bioscience
Jul 08, 2026
CEO, Director
Uninformative Buy
3.00K
$5.00M
Fluent
Apr 17, 2017
Director
Uninformative Buy
―
$1.22M
List of latest transactions for each holding click on a transaction to see Robert Fried's performance on stock
You May Also Like
Robert Fried insider profile FAQ
What is the percentage of profitable transactions made by Robert Fried?
The percentage of profitable transactions made by Robert Fried is 67%.
What is the average return per transaction made by Robert Fried?
The average return per transaction made by Robert Fried is 18.30%.
What stocks does Robert Fried hold?
Robert Fried holds: NAGE, FLNT stocks.
What was Robert Fried’s latest transaction?
Robert Fried latest transaction was an Uninformative Buy of $3.00K.
What was Robert Fried's most profitable transaction?
Robert Fried’s most profitable transaction was an Informative Buy of NAGE stock on June 1, 2023. The return on the trade was 85.20%.
What is Robert Fried's role in Niagen Bioscience?
Robert Fried's role in Niagen Bioscience is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.